Company intelligence / Profile preview

Teramed

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

TeraMed was a medical technology company focused on the development and manufacture of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). The company's primary innovation was the AneuRx stent graft system, which provided a minimally invasive alternative to traditional open surgical repair for aortic diseases. TeraMed's technology aimed to improve patient outcomes by reducing recovery times and procedural risks associated with vascular surgery. The company was a significant player in the early 2000s medtech landscape before its strategic acquisition by a major healthcare conglomerate.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Cordis Corporation

Beyond the preview

Go deeper on Teramed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teramed.

Explore the full profile